New aldose reductase inhibitors as potential agents for the prevention of long-term diabetic complications

By Costantino L.   Rastelli G.   Cignarella G.   Vianello P.   Barlocco D.  

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 8, 1997-08 ,pp. : 843-858

Informa Healthcare

Access to resources Recommend Favorite

Aldose reductase inhibitors: therapeutic implications for diabetic complications

By Oates P.J.   Mylari B.L.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 12, 1999-12 ,pp. : 2095-2119

Informa Healthcare

Access to resources Recommend Favorite

Updates on Aldose Reductase Inhibitors for Management of Diabetic Complications and Non-diabetic Diseases

By  

Mini Reviews in Medicinal Chemistry, Vol. 16, Iss. 2, 2016-01 ,pp. : 120-162

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Studies of Aldose Reductase Enzyme Inhibition for Diabetic Complications

By  

Current Medicinal Chemistry, Vol. 10, Iss. 15, 2003-08 ,pp. : 1329-1352

Bentham Science Publishers

Access to resources Recommend Favorite

Aldose Reductase in Diabetic Microvascular Complications

By  

Current Drug Targets, Vol. 6, Iss. 4, 2005-06 ,pp. : 475-486

Bentham Science Publishers

Access to resources Recommend Favorite